Shingles vaccination in immune-mediated inflammatory diseases: a narrative review.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41578947.
- Also identified by DOI 10.1093/rheumatology/keag043.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There are several pressing reasons to re-examine shingles and strategies for its prevention through vaccination. Firstly, the UK has recently recommended the introduction of a national childhood varicella vaccination programme, and this may impact the epidemiology of shingles. Secondly, treatments for immune-mediated inflammatory diseases are increasingly targeting immunological pathways essential for antiviral defence. Thirdly, we now have access to a highly efficacious shingles vaccine. This review article will explore each of these developments in a way that is globally relevant, incorporating international recommendations.
Medical subject headings
- Herpes Zoster Vaccine
- Herpes Zoster
- Vaccination